Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination

References

• Angel J, Franco MA, Greenberg HB. Rotavirus vaccines: Recent developments and future considereations. Nat Rev Mocrobiol 2007; 5: 527–539
   Web of Science ®Google Scholar
• Arias CF, Dector MA, Segovia L, Lopez T, Camacho M, Isa P, Espinosa R, Lopez S. RNA silencing of rotavirus gene expression. Virus Res 2004; 102: 43–51
   PubMed Web of Science ®Google Scholar
• Bhandari N, Sharma P, Glass RI, Ray P, Greenberg H, Taneja S, Saksena M, Rao CD, Gentsch JR, Parashar U, et al. Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: Results of a randomised controlled trial. Vaccine 2006; 24: 5817–5823
   PubMed Web of Science ®Google Scholar
• Brayden DJ, Baird AW. Microparticle vaccine approaches to stimulate mucosal immunization. Microbes Infect 2001; 3: 867–876
   PubMed Web of Science ®Google Scholar
• Charles MD, Holman RC, Curns AT, Parashar U, Glass R, Bresee J. Hospitalizations associated with rotavirus gastroenteritis in the united states 1993–2002. J Pediar Infect Dis 2006; 25: 489–493
   PubMed Web of Science ®Google Scholar
• Chen SC, Jones DH, Fynan EF. Protective immunity induces by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol 1998; 72: 5757–5761
   PubMed Web of Science ®Google Scholar
• Duncan JD, Wang PX, Harrington CM, Schafer DP, Matsuoka Y, Mestecky JF, Compans RW, Novak MJ. Comparative analysis of oral delivery systems for live rotavirus vaccines. J Contr Rel 1996; 3: 237–247
   Web of Science ®Google Scholar
• Eldridge JH, Gilley RM, Moldeveaunu Z, Stass JK, Meulbroek JA, Tice TR. Biodegradable microspheres: Vaccine delivery system for oral immunization. Curr Top Microbiol Immunol 1989; 146: 59–66
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Hammond CJ, Meulbroek JA, Stass JK, Gilley RM, Tice TR. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches. J Contr Rel 1990; 11: 205–214
   Web of Science ®Google Scholar
• Estes MK, Kang G, Zeng CQ, Crawford SE, Ciarlet M. Pathogenesis of rotavirus gastroenteritis. Novartis Found Symp 2001; 238: 82–96
   PubMed Web of Science ®Google Scholar
• Eldrige JH, Stass JK, Meulbroek JA, Tice TR, Gilley RM. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun 1991; 59: 2978–2986
   PubMed Web of Science ®Google Scholar
• Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006; 24: 2718–2731
   PubMed Web of Science ®Google Scholar
• Glass RI, Gentsch JR, Ivanoff B. New lessons for Rotavirus vaccines. Science 1996; 272: 46–48
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR. Rotavirus vaccines: Current prospects and future challenges. Lancet 2006; 368: 323–332
   PubMed Web of Science ®Google Scholar
• Gutierro I, Hernandez RM, Igartua M, Gascon AR, Pedraz JL. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 2002; 21: 67–77
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Jeffery H, Roberts MJ, Mc Gee JP, Davis SS. Controlled release microparticles for vaccine development. Vaccine 1991; 9: 768–771
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Singh M, Gupta RK. Poly (lactide-co-glycolide) microparticles for the development of single dose controlled release vaccines. Adv Drug Deliv Rev 1998; 32: 225–246
   PubMed Web of Science ®Google Scholar
• Jeffery LC. Single-administration vaccines: c-release technology to mimic repeated immunizations. Trends Biotechnol 1999; 17: 25–29
   PubMed Web of Science ®Google Scholar
• Johansen P, Gander B, Merkle HP, Sesardic D. Ambiguities in the preclinical quality assessment of microparticlulate vaccines. Trends Biotechnol 2000; 18: 203–211
   PubMed Web of Science ®Google Scholar
• Kanchan V, Panda AK. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 2007; 28: 5344–5357
   PubMed Web of Science ®Google Scholar
• Katare YK, Muthukumaran T, Panda AK. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int J Pharm 2005; 301: 149–160
   PubMed Web of Science ®Google Scholar
• Katare YK, Panda AK. Effect of excipients on physical instability, in vitro release and in vivo performances of TT loaded biodegradable polymer microparticles. Eur J Pharm Sci 2006; 28: 179–188
   PubMed Web of Science ®Google Scholar
• Khoury CA, Moser CA, Speaker JJ, Offit PA. Oral inoculation of mice with low doses of microencapsulated, noninfectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue. J Contr Rel 1995; 172: 870–874
   Google Scholar
• Kim B, Bowersock T, Griebel P, Kidane A, Babiuk LA, Sanchez M, Attah-Poku S, Kaushik RS, Mutwiri GK. Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres. J Contr Rel 2002; 85: 191–202
   PubMed Web of Science ®Google Scholar
• Livinghood JR. Rotavirus intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344: 546–572
   Web of Science ®Google Scholar
• Malek MA, Curns AT, Holman RC. Diarrhea and rotavirus associated hospitalizations among children less than 5 years of age: United States, 1997 and 2002. Pediatrics 2006; 117: 1887–1892
   PubMed Web of Science ®Google Scholar
• McNeal MM, Rae MN, Ward RL. Antibody responses and protection stimulated by sequential oral-parenteral immunization of mice with rotavirus. Vaccine 1999; 17: 639–645
   PubMed Web of Science ®Google Scholar
• Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, et al. Rotavirus intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344: 546–572
   Web of Science ®Google Scholar
• Offit PA, Khoury CA, Moser CA, Fred Clark H, Kim JE, Speaker TJ. Enhancement of Rotavirus immunogenicity by microencapsulation. Virology 1994; 203: 134–143
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9: 565–572
   PubMed Web of Science ®Google Scholar
• Raghuvanshi RS, Goyal S, Singh OM, Panda AK. Stabilization of dichloromethane-induced protein denaturation during microencapsulation. Pharm Dev Technol 1998; 3: 269–276
   PubMedGoogle Scholar
• Raghuvanshi RS, Singh OM, Panda AK. Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles. Drug Deliv 2001; 2: 99–106
   Google Scholar
• Raghuvanshi RS, Singh OM, Panda AK. Correlation between in vitro release and in vivo immune response from biodegradable polymer particles entrapping tetanus toxoid. Drug Deliv 2002; 9: 113–120
   PubMed Web of Science ®Google Scholar
• Ray P, Malik J, Singh RK, Bhatnagar S, Bahl R, Kumar R, Bhan MK. Rotavirus non-structural protein NSP4 includes heterotypic antibody responses during natural infection in children. J Infect Dis 2003; 187: 1786–1793
   PubMed Web of Science ®Google Scholar
• Rin R, Ng LS, Wang CH. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 2005; 26: 4476–4485
   PubMed Web of Science ®Google Scholar
• Shaobing Z, Xianmo D, Xiaohong L, Wenxiang J, Li L. Synthesis and characterization of biodegradable low molecular weight aliphatic polyesters and their use in protein-delivery systems. J Appl Polym Sci 2004; 91: 1848–1856
   Web of Science ®Google Scholar
• Sharma S, Ray P, Gentsch JR, Glass RI, Kalra V, Bhan MK. Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007. J Clin Microbiol 2008; 46: 1343–1348
   PubMed Web of Science ®Google Scholar
• Srinivasan C, Katare YK, Muthukumaran T, Panda AK. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles. J Microencapsulation 2005; 2: 127–138
   Web of Science ®Google Scholar
• Sturesson C, Artursson P, Ghaderi R, Johansen K, Mirazimi A, Uhnoo I, Syensson L, Albertsson AC, Carlfors J. Encapsulation of rotavirus into poly (lactide-co-glycolide) microspheres. J Contr Rel 1999; 59: 377–389
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morroul AL, Carter-Campbell S. Rotavirus infection in infants as protection against subsequesnt infections. N Engl J Med 1996; 335: 1022–1028
   PubMed Web of Science ®Google Scholar